You are here: Home » News-CM » Equities » Hot Pursuit
Business Standard

Poly Medicure rises nearly 15% in six sessions

Capital Market 

Poly Medicure surged 6.03% to Rs 1,038.50, extending gains for sixth day in a row.

The stock has added 14.70% in six sessions, from its recent closing low of Rs 905.40 recorded on 18 November 2021.

On a year-to-date (YTD) basis, the stock has zoomed 103.72% while the benchmark Sensex has added 19.95% during the same period.

On the technical front, the stock's RSI (relative strength index) stood at 74.539. The RSI oscillates between zero and 100. Traditionally, the RSI is considered overbought when above 70 and oversold when below 30.

The stock was trading above its 50-day, 100-day and 200-day simple moving average (SMA) placed at 938.32, 948.03 and 915.29, respectively.

Poly Medicure is one of the leading medical devices company and exporter in India. It has 5 manufacturing facilities in India (3 facilities in Faridabad and 1 each in Jaipur and Haridwar), 3 facilities overseas (one facility in Italy - wholly owned subsidiary, one facility in China - wholly owned subsidiary and one joint venture in Egypt).

On a consolidated basis, net profit of Poly Medicure rose 9.20% to Rs 38.23 crore on 11.89% rise in net sales to Rs 223.37 crore in Q2 September 2021 over Q2 September 2020.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Mon, November 29 2021. 15:04 IST